13D Filing: Versant Venture Capital IV, L.P. and Crispr Therapeutics AG (CRSP)

CUSIP No.   71723F103

13D

1.

Name of Reporting Persons
Versant Ventures IV, LLC

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

 o

(b)

 x(1)

3.

SEC Use Only

4.

Source of Funds (See Instructions)
AF

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)     o

6.

Citizenship or Place of Organization
Delaware

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

8.

Shared Voting Power
2,752,256 shares of common stock (2)

9.

Sole Dispositive Power
0

10.

Shared Dispositive Power
2,752,256 shares of common stock (2)

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
2,752,256 shares of common stock (2)

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

13.

Percent of Class Represented by Amount in Row 11
6.78% (3)

14.

Type of Reporting Person (See Instructions)
OO